Circuit-Bio ^{For Profit}

Circuit-Bio is a synthetic biology company that develops gene circuits for cancer immunotherapy. Their platform generates gene circuits that produce a combination of multiple immune-stimulating proteins that are exclusively expressed in targeted tumor cells. The company's approach enables adaptation of each of the circuit components to the patient. They have a pipeline that focuses on colon cancer and breast cancer. Circuit-Bio's team is composed of scientists with expertise in synthetic biology, bioinformatics, cancer immunology, and discovery platform. Contact info: No contact information provided on the main page.